Table 2 Characteristics of participants in the UK Biobank by quartiles of weighted genetic score for height
From: Adult height and risk of 50 diseases: a combined epidemiological and genetic analysis
Characteristic | Weighted genetic score for heighta | |||
|---|---|---|---|---|
Quartile 1 | Quartile 2 | Quartile 3 | Quartile 4 | |
N | 90,170 | 107,870 | 109,390 | 110,004 |
Height (cm)—female | 159.2 (5.7) | 161.6 (5.6) | 163.3 (5.7) | 165.8 (6.0) |
Height (cm)—male | 172.1 (6.2) | 174.7 (6.2) | 176.6 (6.2) | 179.3 (6.5) |
Age | 56.7 (8.0) | 56.8 (8.0) | 56.8 (8.0) | 56.9 (7.9) |
Sex—female | 53.9% | 54.0% | 53.8% | 54.2% |
Body mass index (BMI) | 27.6 (4.9) | 27.5 (4.8) | 27.3 (4.7) | 27.2 (4.7) |
Obese (BMI ≥ 30) | 25.5% | 24.5% | 23.8% | 23.1% |
Waist-hip-ratio (WHR) | 0.87 (0.09) | 0.87 (0.09) | 0.87 (0.09) | 0.87 (0.09) |
Townsend deprivation indexb | 19.5% | 18.2% | 17.8% | 17.4% |
Ever smoker | 46.2% | 46.2% | 45.8% | 45.9% |
Vigorous activityc | 59.4% | 59.7% | 60.1% | 59.4% |
Systolic BP (mmHg) | 141.7 (20.9) | 141.4 (20.7) | 141.0 (20.6) | 140.6 (20.5) |
Diastolic BP (mmHg) | 84.6 (11.3) | 84.4 (11.3) | 84.2 (11.2) | 84.1 (11.3) |
Female only | ||||
 Nulliparous | 18.7% | 18.4% | 18.7% | 19.5% |
 Ever contraceptive pill | 81.9% | 82.0% | 82.2% | 82.0% |
 Ever on hormone replacement therapy | 38.8% | 39.2% | 39.4% | 39.8% |